本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

3.08
-0.0900-2.84%
盘后3.080.00000.00%19:08 EDT
成交量:1.37万
成交额:4.25万
市值:659.90万
市盈率:0.00
高:3.16
开:3.08
低:3.07
收:3.17
52周最高:25.40
52周最低:2.90
股本:214.25万
流通股本:210.50万
量比:0.38
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-1,791.0249
每股收益(LYR):-3,259.3317
净资产收益率:-178.24%
总资产收益率:-66.75%
市净率:1.18
市盈率(LYR):0.00

数据加载中...

2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC问询函

[Cover]Correspondence
2019/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]